AstraZeneca to freely share drug compounds with UK groups
December 5, 2011Research and Development, Sales and Marketing AstraZeneca, research
AstraZeneca will make 22 of its compounds available free of charge to UK academia next year as part of a …
Actelion Pharmaceuticals Takes to the Cloud with Global Deployment of Veeva CRM and iRep
December 5, 2011BARCELONA, Spain – 1 December, 2011 – Before selecting cloud-based Veeva CRM for 500+ users worldwide, Actelion Ltd. had been …
Roche’s Lung cancer test approved for Europe
December 5, 2011Research and Development, Sales and Marketing Roche, Tarceva, lung cancer
A new test which should help to better target treatment of patients with non-small cell lung cancer (NSCLC) has received …
Astellas adds two senior executives at US site
December 5, 2011Business Services, Manufacturing and Production, Sales and Marketing Astellas
Astellas’ US subsidiary Agensys has appointed Frank Hudson as vice president of finance, and Wolfgang Noe as vice president of …
Stroke crisis to hit UK unless government acts, warns report
December 5, 2011Sales and Marketing BMS, Pfizer, Pradaxa, UK, stroke
Major improvements are needed in the treatment of atrial fibrillation to avoid a UK stroke epidemic, according to a new …
Teva gains tentative approval to sell generic Lipitor in 2012
December 5, 2011Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva
Teva has gained a tentative approval by the FDA to sell its generic form of Pfizer’s blockbuster statin Lipitor next …
UK unveils initiatives to support life sciences
December 5, 2011Research and Development, Sales and Marketing ABPI, UK, competitiveness, david cameron
The government has unveiled plans to help support the UK’s life science industries.The new package of measures includes £180 million …
Europe’s €80 billion will support research
December 2, 2011Research and Development, Sales and Marketing European Commission
The European Commission has created a new €80 billion budget in an effort to encourage research and innovation across the …
Boehringer will help develop Aveo’s lung cancer candidate
December 2, 2011Manufacturing and Production
Boehringer Ingelheim has agreed to help oncology specialist firm Aveo develop its lung cancer treatment ficlatuzumab. The agreement is for …
Merck KGaA appoints new heads of corporate auditing and strategy
December 2, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Merck KGaA
Merck KGaA has appointed Dr Friederike Rotsch as its new head of corporate auditing. She reports to Karl-Ludwig Kley, chairman …
Insight Research Group makes three senior appointments
December 2, 2011Business Services, Medical Communications, Sales and Marketing Insight research
Dave Bostock, Natasha Barretto and Jenny Service have all been appointed to senior positions within Insight. Bostock has been appointed …
Biocartis appoints Dr Nayan Gregory Parekh as its new chief executive
December 1, 2011Business Services, Research and Development, Sales and Marketing Biocartis
Biocartis, a Swiss company developing compact molecular diagnostic systems, has announced the appointment of Dr Nayan Gregory Parekh as its …
FDA approves Ranbaxy’s generic Lipitor
December 1, 2011Manufacturing and Production, Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva
The FDA will allow Ranbaxy to develop a generic version of Pfizer’s blockbuster statin Lipitor. The firm has received final …
Discount fails to sway NICE on Gilenya
December 1, 2011Sales and Marketing NICE, Novartis, gilenya
NICE has once again rejected Novartis’ multiple sclerosis pill Gilenya despite the firm offering a patient access scheme. In its …
Watson launches first generic Lipitor in US
November 30, 2011Sales and Marketing Lipitor, Pfizer, Watson, atorvastin
Watson Pharmaceuticals has launched its generic version of Pfizer’s blockbuster statin Lipitor as the drug goes off patent in the …
NICE wishes you a cost effective Christmas
November 30, 2011Sales and Marketing NICE
NICE has disclosed information about its use of corporate credit cards following a request made under the Freedom of Information …
Eli Lilly appoints Richard Ascroft as senior director for the ACE region
November 30, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly
Lilly has appointed Richard Ascroft as senior director, corporate affairs, for the Australia, Canada and Europe (ACE) region. His tasks …
Roche inks $490 million deal with PTC Therapeutics
November 30, 2011Research and Development, Sales and Marketing PTC Therapeutics, Roche
Roche has signed a $490 million deal with specialist biotech firm PTC Therapeutics. Roche is paying PTC $30 million upfront …
NICE rejects Lucentis in diabetic macular oedema
November 29, 2011Sales and Marketing Lucentis, NICE
NICE has rejected Novartis’ Lucentis for diabetic macular oedema. NICE has not recommended Lucentis (ranibizumab) for the treatment of diabetic …
Merck and Merck look to settle Facebook naming dispute
November 29, 2011Medical Communications Facebook, Merck, Merck KGaA
Merck & Co and Merck KGaA looked to have made inroads into their Facebook naming quarrel. Earlier this month Merck …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
